Sleep Medicine
From the Journals
Study questions if blue light–blocking glasses really work
“Our findings do not support the prescription of blue light–filtering lenses to the general population.”
News
Inhaling pleasant scents during sleep tied to a dramatic boost in cognition
“To my knowledge, that level of [memory] improvement is far greater than anything that has been reported for healthy older adults ...”
Latest News
Poor sleep tied to increased injury from falls, motor vehicle accidents
Adults who get 4 hours or less nightly and those who have trouble staying asleep are significantly more likely to be injured.
Conference Coverage
Smart-bed technology reveals insomnia, flu risk link
Sleep disorders, including insomnia, can dampen immune function and an individual’s ability to fight off illness.
From the Journals
Poor outcomes in fibrotic ILD attributed to nocturnal hypoxemia
In patients with fibrotic interstitial lung disease, nocturnal hypoxemia is associated with poor clinical outcomes.
Conference Coverage
Regular, optimal sleep tied to lower mortality risk
“If sleep were an 8-hour pill, it would be beneficial to take the full dose at regular times consistently.”
Conference Coverage
Suicidality risk in youth at highest at night
The findings “signal potentially that there’s a need for support, particularly at nighttime, and that there might be a potential of targeting self...
Feature
Unlocking the riddle of REM sleep
In general, as long as you get enough sleep in the first place, you will get enough REM. “You can’t control the amount of REM sleep you have.”
Latest News
Potential new treatment for REM sleep behavior disorder
The disorder can signal risk for synucleinopathies, a group of neurological conditions such as Parkinson's disease that involve the formation of...
Conference Coverage
Standard measure may underestimate OSA in Black patients
Measurement error may be the culprit in underdiagnosing obstructive sleep apnea in Black patients.
From the Journals
Which drug best reduces sleepiness in patients with OSA?
“Although solriamfetol appears most effective, comorbid hypertension and costs may be barriers to its use.”